Section 6 of BDA : Section 6: Application For Intellectual Property Rights Not To Be Made Without Approval Of National Biodiversity Authority
BDA
JavaScript did not load properly
Some content might be missing or broken. Please try disabling content blockers or use a different browser like Chrome, Safari or Firefox.
Explanation using Example
Imagine a pharmaceutical company based in the United States, which has conducted extensive research on a plant species indigenous to India, known for its unique medicinal properties. The company has discovered a compound within the plant that can be used to create a new drug to treat a widespread disease. Before the company can file for a patent on this new drug in the U.S. or elsewhere, Section 6 of The Biological Diversity Act, 2002 requires them to obtain prior approval from the National Biodiversity Authority (NBA) in India.
The company submits an application to the NBA fo...
Login to access all pages and read more content.
To disable ads and read rest of the premium content, subscribe to KanoonGPT Pro.
KanoonGPT is now faster and smarter, powered by upgraded servers.
Subscribe today and unlock all new features!